New class drug significantly reduces spine fracture risk in postmenopausal women with osteoporosis

New class drug significantly reduces spine fracture risk in postmenopausal women with osteoporosis

In postmenopausal women with osteoporosis, 12 months treatment with romosozumab was associated with rapid and large reductions in their risk of a vertebral fracture compared to placebo, research shows.

Source: Science Daily

Read More

  • American Academy of Orthopaedic Surgeons
  • North American Spine Society
  • Fairview
  • Minnesota Valley Surgery Center
  • St. Francis Regional Medical Center
  • Haemochromatosis Australia - Inherited iron overload disorder